Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Central Venous Pressure | 1 | 2010 | 5 | 0.320 |
Why?
|
| Fluid Therapy | 1 | 2010 | 25 | 0.310 |
Why?
|
| Glottis | 1 | 2007 | 7 | 0.270 |
Why?
|
| Oropharynx | 1 | 2007 | 9 | 0.270 |
Why?
|
| Mucous Membrane | 1 | 2007 | 27 | 0.270 |
Why?
|
| Catheterization | 1 | 2007 | 55 | 0.260 |
Why?
|
| Trachea | 1 | 2007 | 53 | 0.260 |
Why?
|
| Postoperative Complications | 3 | 2013 | 823 | 0.230 |
Why?
|
| Esophagus | 1 | 2004 | 28 | 0.210 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 58 | 0.210 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2013 | 77 | 0.140 |
Why?
|
| Coronary Artery Bypass | 3 | 2013 | 100 | 0.120 |
Why?
|
| Factor IX | 1 | 2013 | 11 | 0.100 |
Why?
|
| Postoperative Hemorrhage | 1 | 2013 | 38 | 0.100 |
Why?
|
| Intensive Care Units | 2 | 2010 | 121 | 0.090 |
Why?
|
| Aged | 6 | 2013 | 10260 | 0.080 |
Why?
|
| Middle Aged | 6 | 2013 | 11848 | 0.080 |
Why?
|
| Female | 7 | 2013 | 19942 | 0.080 |
Why?
|
| Observer Variation | 1 | 2010 | 96 | 0.080 |
Why?
|
| Adult | 4 | 2013 | 9256 | 0.080 |
Why?
|
| Clinical Protocols | 1 | 2010 | 77 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 77 | 0.080 |
Why?
|
| Catheterization, Central Venous | 1 | 2010 | 62 | 0.080 |
Why?
|
| Ranitidine | 1 | 2009 | 3 | 0.070 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2009 | 3 | 0.070 |
Why?
|
| Peptic Ulcer | 1 | 2009 | 5 | 0.070 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2009 | 11 | 0.070 |
Why?
|
| Cross Infection | 1 | 2009 | 57 | 0.070 |
Why?
|
| Multiple Trauma | 1 | 2007 | 41 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 395 | 0.060 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 98 | 0.060 |
Why?
|
| Male | 6 | 2013 | 19437 | 0.060 |
Why?
|
| Humans | 7 | 2013 | 32274 | 0.060 |
Why?
|
| Anesthesia, General | 1 | 2004 | 30 | 0.050 |
Why?
|
| Aortic Valve Stenosis | 1 | 2004 | 40 | 0.050 |
Why?
|
| Pipecolic Acids | 1 | 2003 | 7 | 0.050 |
Why?
|
| Thrombocytopenia | 1 | 2003 | 30 | 0.050 |
Why?
|
| Radiography | 1 | 2004 | 362 | 0.050 |
Why?
|
| Heparin | 1 | 2003 | 65 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 907 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 502 | 0.050 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2002 | 4 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 3898 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2003 | 122 | 0.040 |
Why?
|
| Anesthesia | 1 | 2002 | 63 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2004 | 427 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 465 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2013 | 1840 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2013 | 3416 | 0.030 |
Why?
|
| Chest Tubes | 1 | 2013 | 5 | 0.030 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2013 | 4 | 0.030 |
Why?
|
| Blood Coagulation Disorders | 1 | 2013 | 11 | 0.020 |
Why?
|
| Antifibrinolytic Agents | 1 | 2013 | 14 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2013 | 3624 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 264 | 0.020 |
Why?
|
| Anti-Ulcer Agents | 1 | 2009 | 4 | 0.020 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2009 | 14 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 90 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 128 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 141 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 155 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2009 | 174 | 0.020 |
Why?
|
| Age Distribution | 1 | 2009 | 194 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 238 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 651 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 743 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2009 | 773 | 0.020 |
Why?
|
| Incidence | 1 | 2009 | 1241 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 3934 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 2240 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 1425 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 2003 | 22 | 0.010 |
Why?
|
| Preanesthetic Medication | 1 | 2002 | 3 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2002 | 6 | 0.010 |
Why?
|
| Critical Illness | 1 | 2003 | 87 | 0.010 |
Why?
|
| Oxygen | 1 | 2002 | 138 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 98 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2002 | 164 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2002 | 100 | 0.010 |
Why?
|